rare neurological disorders

1 articles
The Motley FoolThe Motley Fool··Seena Hassouna

Major Biotech Backer Exits Harmony Biosciences Completely

Bridge City Capital exits $7.77M Harmony Biosciences stake completely. Stock down 42% versus S&P 500 over past year, raising investor confidence concerns.
HRMYbiotechunderperformance